Stock listing

Recce Pharmaceuticals Ltd.

Selected listing: R9Q · TRADEGATE · EUR · DE

Recce Pharmaceuticals Ltd. (Tradegate:R9Q), Health Technology. Latest release Aug 31, 2026: Appendix 4E and FY26 Annual Report.

R9Q:TRADEGATEEURDEUpdated October 2, 2026

Ticker: Tradegate:R9Q
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Tradegate
Currency: EUR

About Recce Pharmaceuticals Ltd.

Recce Pharmaceuticals Ltd. (RCE) is listed on 6ix with investor news, events, company updates, and market data in one place. Follow the company page to track new releases, upcoming presentations, and the latest information available on 6ix.

Latest news from Recce Pharmaceuticals Ltd.

Appendix 4E and FY26 Annual Report

August 31, 2026

HREC Approves Comparator Study for Pivotal Phase 3 DFI

August 18, 2026

Vietnamese Patent Granted for RECCE Anti-Infectives

July 13, 2026

AUD $3.7M Income Tax Refund Received

June 30, 2026

Placement & SPP to raise $8 million

June 25, 2026

All Recce Pharmaceuticals Ltd. news →

Research Recce Pharmaceuticals Ltd.

Recce Pharmaceuticals Ltd. company profile

View the public company page for Recce Pharmaceuticals Ltd. on 6ix.

Recce Pharmaceuticals Ltd. news

Read company news and market updates connected to Recce Pharmaceuticals Ltd..

Recce Pharmaceuticals Ltd. investor events

Find investor webinars, events, and replay context for Recce Pharmaceuticals Ltd..